Gastrointestinal Hemorrhage Clinical Trial
Official title:
The Clinical Feature of the Exposed Vessels in Ulcer Base Over Time After Prophylactic Argon Plasma Coagulation in Colonic Endoscopic Mucosal Resection
The prophylactic APC right after colonic EMR doesn't mean the complete coagulation of
visible vessel because of injection material.
The aim of this study was to evaluate the clinical feature of the visible vessels in ulcer
base over time after prophylactic APC in colonic EMR.
The prophylactic Argon plasma coagulation (APC) of non-bleeding visible vessels seems not to have an additional advantage in the prevention of delayed post polypectomy bleeding in recently studies. However, immediate APC after endoscopic mucosal resection (EMR) may not mean the complete coagulation of exposed vessels because of injection material. The aim of this study was to evaluate the clinical feature of the exposed vessels in ulcer base over time after prophylactic APC in colonic EMR. Methods: This study was designed as a prospective study. Investigators excluded diminutive polyp, large polyp (> 2cm), long stalk pedunculated polyp, and clear ulcer base after EMR. Between August 2013 and May 2014, patients who were enrolled underwent prophylactic APC for non-bleeding visible vessels after colonic endoscopic mucosal resection. After checking the complete coagulation of visible vessels, the numbers of visible vessel group were counted by lap of time such as 1, 3, 5, and 7 min in ulcer base. ;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02903017 -
Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage
|
Phase 4 | |
| Recruiting |
NCT02514304 -
Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding
|
||
| Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
| Completed |
NCT01477320 -
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
|
N/A | |
| Completed |
NCT02105532 -
Transfusion in Gastrointestinal Bleeding
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT01549418 -
The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin
|
Phase 4 | |
| Recruiting |
NCT05226221 -
Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
|
||
| Active, not recruiting |
NCT02874326 -
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber
|
Phase 2 | |
| Completed |
NCT02928939 -
Therapeutic Conflicts and Multimorbidity
|
||
| Withdrawn |
NCT01215058 -
Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer
|
N/A | |
| Completed |
NCT01029626 -
Glasgow-Blatschford Score Validation in Digestive Hemorrhage
|
N/A | |
| Completed |
NCT00251979 -
A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer
|
Phase 3 | |
| Completed |
NCT02991612 -
Rifaximin in Patients With Gastroesophageal Variceal Bleeding
|
N/A | |
| Recruiting |
NCT02964195 -
Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding
|
N/A | |
| Terminated |
NCT02609100 -
Video Capsule Endoscopy Versus Colonoscopy in Patients With Melena and Negative Upper Endoscopy
|
N/A | |
| Completed |
NCT02965209 -
European Novel Motorized Spiral Endoscopy Trial
|
N/A | |
| Completed |
NCT01872286 -
Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2
|
N/A | |
| Completed |
NCT02349490 -
Seraseal for Endoscopic Hemostasis
|
Phase 4 | |
| Withdrawn |
NCT01005147 -
Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
|
N/A | |
| Completed |
NCT00570973 -
Band Ligation Versus Transjugular Intrahepatic Portosystemic Stent Shunt (TIPS) in Cirrhotics With Recurrent Variceal Bleeding Non Responding to Medical Therapy
|
Phase 4 |